title: Different evidence of key amprenavir resistance mutations on the efficacy of darunavir.
authors.forename: Antonio
authors.initials: A
authors.lastname: Di Biagio
authors.forename: Raffaella
authors.initials: R
authors.lastname: Rosso
authors.forename: Bianca
authors.initials: B
authors.lastname: Bruzzone
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cenderello
authors.forename: Chiara
authors.initials: C
authors.lastname: Dentone
authors.forename: Alessandra
authors.initials: A
authors.lastname: Mularoni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ferrea
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Icardi
authors.forename: Claudio
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D002219:Carbamates / Q000494:pharmacology / Q000627:therapeutic use*; D000069454:Darunavir; D024882:Drug Resistance, Viral / Q000235:genetics*; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D019438:Ritonavir; D000069454:Darunavir